These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9653042)

  • 21. Structure-function studies of the HIV-1 coreceptors.
    Berson JF; Doms RW
    Semin Immunol; 1998 Jun; 10(3):237-48. PubMed ID: 9653050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemokine receptors and the clinical course of HIV-1 infection.
    de Roda Husman AM; Schuitemaker H
    Trends Microbiol; 1998 Jun; 6(6):244-9. PubMed ID: 9675802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [New kinds of AIDS drugs inhibit HIV entry into the cell. Entry inhibitors soon for oral administration].
    Fätkenheuer G
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():46-8. PubMed ID: 16385874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Control of HIV-1 infection by soluble factors of the immune response.
    DeVico AL; Gallo RC
    Nat Rev Microbiol; 2004 May; 2(5):401-13. PubMed ID: 15100693
    [No Abstract]   [Full Text] [Related]  

  • 25. A brief update on chemokines, chemokine receptors, and HIV.
    Bean P
    Am Clin Lab; 2002 Jul; 21(6):14-6. PubMed ID: 12224175
    [No Abstract]   [Full Text] [Related]  

  • 26. Chemokine control of HIV-1 infection.
    Mellado M; Rodríguez-Frade JM; Vila-Coro AJ; de Ana AM; Martínez-A C
    Nature; 1999 Aug; 400(6746):723-4. PubMed ID: 10466720
    [No Abstract]   [Full Text] [Related]  

  • 27. Proliferative activation up-regulates expression of CD4 and HIV-1 co-receptors on NK cells and induces their infection with HIV-1.
    Harada H; Goto Y; Ohno T; Suzu S; Okada S
    Eur J Immunol; 2007 Aug; 37(8):2148-55. PubMed ID: 17628860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Roles of chemokines and chemokine receptors in HIV-1 infection.
    Murakami T; Yamamoto N
    Int J Hematol; 2000 Dec; 72(4):412-7. PubMed ID: 11197206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood groups and susceptibility to virus infection: new developments.
    Branch DR
    Curr Opin Hematol; 2010 Nov; 17(6):558-64. PubMed ID: 20739878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cocaine and sigma-1 receptors modulate HIV infection, chemokine receptors, and the HPA axis in the huPBL-SCID model.
    Roth MD; Whittaker KM; Choi R; Tashkin DP; Baldwin GC
    J Leukoc Biol; 2005 Dec; 78(6):1198-203. PubMed ID: 16204638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamic reorganization of chemokine receptors, cholesterol, lipid rafts, and adhesion molecules to sites of CD4 engagement.
    Nguyen DH; Giri B; Collins G; Taub DD
    Exp Cell Res; 2005 Apr; 304(2):559-69. PubMed ID: 15748900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potent broad cross-neutralizing sera inhibit attachment of primary HIV-1 isolates (groups M and O) to peripheral blood mononuclear cells.
    Beirnaert E; De Zutter S; Janssens W; van der Groen G
    Virology; 2001 Mar; 281(2):305-14. PubMed ID: 11277702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreasing sensitivity to RANTES (regulated on activation, normally T cell-expressed and -secreted) neutralization of CC chemokine receptor 5-using, non-syncytium-inducing virus variants in the course of human immunodeficiency virus type 1 infection.
    Koning FA; Kwa D; Boeser-Nunnink B; Dekker J; Vingerhoed J; Hiemstra H; Schuitemaker H
    J Infect Dis; 2003 Sep; 188(6):864-72. PubMed ID: 12964118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current concepts in HIV/AIDS.
    Martin D
    SADJ; 1999 Dec; 54(12):609-15. PubMed ID: 16892569
    [No Abstract]   [Full Text] [Related]  

  • 35. Determinants of the natural history of human immunodeficiency virus type 1 infection.
    Phair JP
    J Infect Dis; 1999 Mar; 179 Suppl 2():S384-6. PubMed ID: 10081512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dichotomous effects of C-C chemokines in HIV-1 pathogenesis.
    Ansari AW; Heiken H; Moenkemeyer M; Schmidt RE
    Immunol Lett; 2007 May; 110(1):1-5. PubMed ID: 17434211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outstanding questions on HIV vaccine trial.
    Jefferys R; Harrington M
    Science; 2004 Jul; 305(5681):180; author reply 180. PubMed ID: 15247456
    [No Abstract]   [Full Text] [Related]  

  • 38. HIV. Escape artist par excellence.
    Cohen J
    Science; 2003 Mar; 299(5612):1505-8. PubMed ID: 12624245
    [No Abstract]   [Full Text] [Related]  

  • 39. HIV/AIDS: allied responses.
    Mascola JR
    Nature; 2007 Sep; 449(7158):29-30. PubMed ID: 17805280
    [No Abstract]   [Full Text] [Related]  

  • 40. Virology. HIV may shed some protection as it jumps to new hosts.
    Cohen J
    Science; 2004 Mar; 303(5666):1956. PubMed ID: 15044774
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.